Tesaro, Inc. (NASDAQ:TSRO) Ratings Summary on May 17, 2018

May 17, 2018 - By Jack Shaw

Tesaro, Inc. (NASDAQ:TSRO) Corporate Logo
During 2017 Q4 the big money sentiment decreased to 1.01. That’s change of 0.20, from 2017Q3’s 1.21. 46 investors sold all, 64 reduced holdings as Tesaro, Inc. ratio dropped. 72 grew holdings while 39 funds amassed holdings. Funds hold 57.95 million shares thus 0.57% less from 2017Q3’s 58.28 million shares.
Kazazian Asset Management Ltd Llc, a New York-based fund reported 7,806 shs. Proshare Advisors Limited Liability Company invested in 0.02% or 30,324 shs. Kistler invested 0% in Tesaro, Inc. (NASDAQ:TSRO). Parallax Volatility Advisers Limited Partnership holds 8,943 shs. Hanson Mcclain Inc holds 0% or 100 shs in its capital. Sabby Mngmt reported 9,700 shs. America First Advisors Lc has 0.03% invested in Tesaro, Inc. (NASDAQ:TSRO). Btg Pactual Asset Mngmt has invested 0.11% of its capital in Tesaro, Inc. (NASDAQ:TSRO). Macquarie Gru Ltd reported 115,354 shs. Oregon Public Employees Retirement Fund invested 0.02% of its capital in Tesaro, Inc. (NASDAQ:TSRO). Whittier Tru Company Of Nevada accumulated 598 shs or 0% of the stock. Moreover, Spark Investment Limited Liability Corporation has 0.36% invested in Tesaro, Inc. (NASDAQ:TSRO). Shell Asset Mgmt holds 0% of its capital in Tesaro, Inc. (NASDAQ:TSRO) for 1,450 shs. Rhumbline Advisers holds 39,477 shs. Element Mngmt Limited Liability has 196,715 shs for 0.4% of their capital.

Tesaro, Inc. registered $61.19 million net activity with 9 buys and 7 selling transactions since March 1, 2018. On Thursday, March 1 2,575 shs were sold by PEARSON TIMOTHY R, worth $141,265. On Friday, March 2 $8.35 million worth of Tesaro, Inc. (NASDAQ:TSRO) was bought by SANDELL SCOTT D. On Thursday, March 1 a trade for 3,855 shs valued at $211,485 was made by Hedley Mary Lynne. MOULDER LEON O JR bought 5,000 shs worth $284,640. Bogle Grant C. had sold 1,809 shs worth $99,224. On Thursday, March 1 the insider Farmer Joseph L sold $144,501.

Tesaro, Inc. (NASDAQ:TSRO) Ratings Coverage

In total 15 analysts cover Tesaro (NASDAQ:TSRO). “Buy” rating has 12, “Sell” are 0, while 3 are “Hold”. 80% are bullish. 18 are the (NASDAQ:TSRO)’s analyst reports since November 28, 2017 according to StockzIntelligence Inc. On Wednesday, May 2 the stock has “Buy” rating by Argus Research. On Wednesday, February 28 the company was maintained by Credit Suisse. On Thursday, January 18 the company was maintained by Piper Jaffray. On Wednesday, February 28 the firm has “Buy” rating by Wells Fargo given. On Thursday, February 22 Evercore upgraded the shares of TSRO in report to “Outperform” rating. On Wednesday, January 3 the stock of Tesaro, Inc. (NASDAQ:TSRO) has “Buy” rating given by Guggenheim. On Tuesday, March 27 the rating was maintained by Wedbush with “Buy”. The company rating was maintained by Credit Suisse on Friday, May 4. On Wednesday, February 28 the firm earned “Buy” rating by Leerink Swann. On Friday, May 4 the firm earned “Buy” rating by H.C. Wainwright. Listed here are Tesaro, Inc. (NASDAQ:TSRO) PTs and latest ratings.

07/05/2018 Broker: Lake Street Rating: Buy New Target: $80.0000 Maintain
04/05/2018 Broker: Bank of America Old Rating: Buy New Rating: Buy Old Target: $94 New Target: $88 Maintain
04/05/2018 Broker: Credit Suisse Old Rating: Outperform New Rating: Outperform Old Target: $141 New Target: $128 Maintain
04/05/2018 Broker: Citigroup Old Rating: Buy New Rating: Buy Old Target: $102 New Target: $100 Maintain
04/05/2018 Broker: H.C. Wainwright Rating: Buy New Target: $104.0000 Maintain
02/05/2018 Broker: Argus Research Old Rating: Buy New Rating: Buy Old Target: $154 New Target: $110 Maintain
16/04/2018 Broker: Piper Jaffray Rating: Hold Maintain
27/03/2018 Broker: Wedbush Rating: Buy New Target: $76.0000 Maintain
28/02/2018 Broker: Cowen & Co Rating: Hold New Target: $66.0 Maintain
01/03/2018 Broker: Morgan Stanley Old Rating: Overweight New Rating: Overweight Old Target: $156 New Target: $146 Maintain

Ticker’s shares touched $50.58 during the last trading session after 3.47% change.Tesaro, Inc. has volume of 673,653 shares. Since May 17, 2017 TSRO has declined 63.82% and is downtrending. The stock underperformed the S&P500 by 75.37%.

Tesaro, Inc., an oncology-focused biopharmaceutical company, identifies, acquires, develops, and commercializes cancer therapeutics and oncology supportive care products in the United States.The company has $2.77 billion market cap. It markets Rolapitant, a neurokinin-1, or NK-1, receptor antagonist for the prevention of chemotherapy induced nausea and vomiting under the VARUBI brand name.Currently it has negative earnings. The firm is also developing Niraparib, an orally active and potent poly polymerase inhibitor, which is in various clinical trials to treat ovarian or breast cancers.

A couple more Tesaro, Inc. (NASDAQ:TSRO) news were posted by: Streetinsider.com which released on May 16, 2018 “TESARO (TSRO) Announces Presentations of Abstracts at ASCO”, also Nasdaq.com on May 16, 2018 posted “TESARO Announces Presentations of Abstracts at the 2018 American Society of Clinical Oncology (ASCO) Annual …”, the next Globenewswire.com is “TESARO Announces Participation in Two Investor Conferences” on May 01, 2018. Globenewswire.com has article titled “TESARO Announces First-Quarter 2018 Operating Results”.

Tesaro, Inc. (NASDAQ:TSRO) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.